Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-734735
Filing Date
2016-10-11
Accepted
2016-10-11 07:06:58
Documents
8
Period of Report
2016-12-01
Effectiveness Date
2016-10-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A d257749ddef14a.htm DEF 14A 777875
2 GRAPHIC g257749g00t28.jpg GRAPHIC 97190
3 GRAPHIC g257749g09i36.jpg GRAPHIC 23102
4 GRAPHIC g257749g42x55.jpg GRAPHIC 27891
5 GRAPHIC g257749g44q86.jpg GRAPHIC 99476
6 GRAPHIC g257749g48d64.jpg GRAPHIC 67422
7 GRAPHIC g257749g78s94.jpg GRAPHIC 94011
8 GRAPHIC g257749g91v69.jpg GRAPHIC 78263
  Complete submission text file 0001193125-16-734735.txt   1450947
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-26642 | Film No.: 161929343
SIC: 2835 In Vitro & In Vivo Diagnostic Substances